Carduso Capital
Carduso Capital is a Groningen-based venture capital firm co-initiated by the University of Groningen and UMCG that invests €100K-€5M in Life Sciences, Energy, and Sustainable Society technology companies, primarily academic spin-offs in Northern Netherlands.
- Company typePrivate
- Founded2016
- HeadquartersGroningen, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Carduso Capital does
Carduso Capital B.V. is a private venture capital firm headquartered in Groningen, Netherlands, that provides equity capital to technology companies. The firm was co-initiated by the University of Groningen (RUG) and University Medical Centre Groningen (UMCG) and invests across three verticals: Life Sciences, Energy, and Sustainable Society. It deploys between €100,000 and €5,000,000 per company, typically at seed to early-growth stage, with a clear orientation toward academic spin-offs and research-driven ventures. The portfolio comprises approximately 18 companies spanning medical devices, diagnostics, biotech, and clean-technology adjacencies, including PureIMS, IVY Medical, QDI, ViroTact, BioBTX, EV Biotech, and eRoutes.
The firm earns returns through carried interest on successful portfolio exits and management fees on committed capital from its limited partners. Its LP base includes Achmea Innovaction Fund, the European Investment Fund, Investeringsfonds Groningen, RUG/UMCG, and The NOM, providing a mix of regional, corporate, and institutional capital. Carduso is led by three managing partners — Frits Kok, Koos Koops, and Robert Polano — who combine corporate finance, pharmaceutical drug development, and high-tech SME entrepreneurship expertise. The firm's value proposition centres on offering both capital and active management support, leveraging an international network and an internal Seed-facility for flexible investment sizing within a regional Northern Netherlands footprint.
Carduso Capital firmographics
Firmographics- Name
- Carduso Capital
- Legal name
- Carduso Capital B.V.
- Website
- https://cardusocapital.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Carduso Capital is a Groningen-based venture capital firm co-initiated by the University of Groningen and UMCG that invests €100K-€5M in Life Sciences, Energy, and Sustainable Society technology companies, primarily academic spin-offs in Northern Netherlands.
- Ownership category
- akta.pro rank
Carduso Capital industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Finance Services (6199)
- akta.pro primary industry
- Venture Debt Providers (FSANAAAL)
Keywords
Where Carduso Capital is headquartered
LocationHeadquarters
- HQ city
- Groningen
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Carduso Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Carried Interest / Performance Fees: Returns generated from successful portfolio company exits, typically a percentage of profits above a defined hurdle rate.
- Management Fees: Ongoing fees charged on committed capital to cover fund operations and management activities.
Distribution channels1 record
Marketing channels2 records
Carduso Capital product offering
Product offeringCore offering
Carduso Capital is a venture capital fund that provides equity risk capital and management support to technology companies, primarily university spin-offs linked to Rijksuniversiteit Groningen (RUG) and University Medical Centre Groningen (UMCG). The fund invests across seed, early, and growth stages in Life Sciences, Energy, and Sustainable Society sectors, with investment tickets ranging from €100K to €5,000K per company, and participates in multiple funding rounds per portfolio company.
Product overview
Carduso Capital is a venture capital company based in Groningen, Netherlands. It participates with equity capital in companies across various business stages from seed to growth capital. The investment focus areas are Life Sciences, Energy, and Sustainable Society, with a strong emphasis on companies with ties to the University of Groningen (RUG) and University Medical Centre Groningen (UMCG). Carduso Capital's minimum investment ticket is 100K euros and maximum is 4,500K euros per company. The company provides financing alongside management support and strategic knowledge to innovative technology companies. The portfolio includes companies such as VRelax (VR app for healthcare), ViroTact (COVID-19 diagnostic test), CC Diagnostics (cervical cancer detection), IVY Medical (infusion pumps), PureIMS (inhalation medication systems), QDI (quantum dot X-ray technology), BUKU (digital study book platform), BioBTX (biomass conversion technology), Agile Biotics (antibiotics development), Brainscan BV (psychiatric diagnostics), Bioron (fibrosis treatment), DEAM (surgical instruments), EV Biotech (cellular factories), Gum Care (dental devices), Notoxins (hyperhidrosis treatment), Pims-e (inhalation technology), Pulmotech (sensor catheters), and eRoutes (recreational route platform).
Differentiator
Problem solved
Functional benefit
Products and services
- Equity Venture Capital Investment
- Management Support & Strategic Knowledge
Companies that use Carduso Capital
Customer profileSegments3 records
Ideal customer profiles2 records
Carduso Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Carduso Capital partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Campus GroningencoreRegional partner supporting access to financing and business development for start-ups in the Groningen ecosystem.
- Carbohydrate Competence CentercoreResearch center focused on carbohydrate technology, providing scientific expertise and potential deal flow for life sciences investments.
- Energy Academy EuropecoreKnowledge institution focused on energy transition research, connecting Carduso Capital to energy sector innovations and talent.
- Energy Transition Centre (En-TRANCE)coreCenter focused on energy transition research and development, supporting sustainable energy investment opportunities.
- Groningen @workminorRegional economic development initiative connecting businesses and supporting employment growth in Groningen.
- Innolab ChemieminorChemical industry incubator supporting innovation and startup development in the chemistry sector.
- Rijksuniversiteit Groningen (RUG)coreCo-initiator of Carduso Capital. Primary source of university spin-offs and research commercialization. University of Groningen provides technology transfer and deal flow.
- Watercampus LeeuwardenminorKnowledge campus focused on water technology innovation, connecting Carduso to water sector opportunities.
Recent moves5 records
Expansion highlights4 records
Carduso Capital competitors and assessment
Company assessmentBroad incumbents
- LSP (Life Sciences Partners): Large Dutch/European healthcare and life sciences specialist. Operates in the same primary vertical (Life Sciences) as Carduso's largest portfolio segment, but at materially larger fund size.
- Forbion: Leading European life sciences VC with Dutch roots, investing across a broader set of stages and ticket sizes. Same Dutch life-sciences vertical but operating at much larger scale.
Regional players
- Capricorn Partners: Belgium-based independent VC manager with sustainable and life sciences funds. Comparable European thematic (sustainability + life sciences) fund-of-funds / direct-investment mix.
- Innovatiefonds Noord-Holland: Regional Dutch innovation fund providing equity to innovative SMEs in North Holland. Similar regional-development mandate and ticket-size range to Carduso.
- PPM Oost: Regional development fund for East Netherlands providing equity to SMEs and start-ups. Comparable regional Dutch investment mandate, though it is broader than pure academic spin-offs.
Direct peers
- Shift Invest: Dutch impact VC investing in sustainable and life-sciences start-ups including university spin-offs. Comparable thematic alignment with Carduso's Sustainable Society and Life Sciences pillars.
- BioGeneration Ventures: Dutch venture capital firm dedicated to early-stage life sciences investments, including academic spin-offs. Strongly comparable sector specialisation and Dutch base.
- Delft Enterprises: TU Delft's technology-transfer and seed investment fund for university spin-offs. Closely analogous boutique regional VC anchored to a single Dutch research university.
- Utrecht Holdings: The VC/technology-transfer arm of Utrecht University, co-investing in academic spin-offs. Directly comparable to Carduso's RUG/UMCG-linked academic spin-off investment model in the Netherlands.
- UNIIQ: South Holland regional proof-of-concept fund backing early-stage tech and life-sciences spin-offs. Comparable in ticket size, sector mix, and Dutch regional VC positioning to Carduso.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Carduso Capital social profiles
Digital presenceCarduso Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Carduso Capital leadership team
Management profileNumber of profiles
Profiles3 records
Carduso Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Carduso Capital M&A and investment
M&A and investmentM&A
Investments6 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Carduso Capital
What does Carduso Capital do?
Carduso Capital is a venture capital fund that provides equity risk capital and management support to technology companies, primarily university spin-offs linked to Rijksuniversiteit Groningen (RUG) and University Medical Centre Groningen (UMCG). The fund invests across seed, early, and growth stages in Life Sciences, Energy, and Sustainable Society sectors, with investment tickets ranging from €100K to €5,000K per company, and participates in multiple funding rounds per portfolio company.
Is Carduso Capital a public or private company?
Carduso Capital is a private company. It is classified as corporate owned and is currently operating.
When was Carduso Capital founded?
Carduso Capital was founded in 2016. It employs 1 to 10 people.
Where is Carduso Capital based?
Carduso Capital is headquartered in Groningen, Netherlands, in the Europe region.
How does Carduso Capital make money?
Two revenue lines are on record. Carried Interest / Performance Fees are the primary driver. The others are management Fees.
Who are Carduso Capital's main competitors?
Broad incumbents on record are LSP (Life Sciences Partners) and Forbion. Regional players are Capricorn Partners, Innovatiefonds Noord-Holland and PPM Oost. Direct peers are Shift Invest, BioGeneration Ventures, Delft Enterprises, Utrecht Holdings and UNIIQ.
Does Carduso Capital have an API?
No public API is recorded for Carduso Capital.
What industry is Carduso Capital in?
Carduso Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAL, Venture Debt Providers. Its NAICS code is 523940 and its SIC code is 6199.